MAPK8 and hepatocellular carcinoma: Compounds that potently interfere with JNK-Smad signaling may be a new therapeutic target for HCC, and Smad phospho-isoform signaling can be a useful predictive biomarker for early assessment of pharmacologic interventions intended to suppress human fibro-carcinogenesis of the liver.